Back to search

National and Kapodistrian University of Athens

Investigation of daily life among older adults with sarcopenia

Abstract

dc:description

Background: Sarcopenia is a muscle disorder, prevalent in the aging population. Sarcopenia leads to adverse health outcomes, such as falls, fractures, impaired functionality, and poor quality of life. Health professionals may prevent, delay, treat, and sometimes even reverse sarcopenia by way of early detection and evidence-based interventions. Nurses spend a lot of time working next to older adults. Therefore, their role in managing sarcopenia and the screening process is of great importance. Objective: To investigate the relationship between sarcopenia and health indicators and factors of daily life in a sample of the Greek older population. More specifically this study aims to translate and validate the SARC-F screening tool in Greek and explore the relationship between different concepts of sarcopenia and functionality, fatigue, and sleep patterns. Methods: For the translation and validation of SARC-F the recommended steps by European Union Geriatric Medicine Society (EUGMS) Sarcopenia Special Interest Group were followed. The SARC-Calf tool was created by the combination of SARC-F and calf circumference. A cross-sectional study was conducted among community-dwelling older adults, using a convenience sampling method. The participants were recruited from July 2020 to October 2022, either as outpatients or their companions in a Greek public hospital or community settings and organizations. They were included in the study if they were ≥ 65 years old, able to walk with or without the use of an aid, able to communicate in Greek, willing to complete the survey, and provided written consent to participate. Individuals were excluded if they met the following criteria: severe cognitive disorders, making unreliable the communication and the information retrieval, having a pacemaker or implanted defibrillator due to the use of a bioimpedance analysis (BIA) device, suffering from acute or chronic health problems that do not allow them to answer questionnaires and perform the required measurements, providing no writing consent. Participant information was collected through face-to-face interviews. For the diagnosis of sarcopenia muscle strength was assessed by a digital hand-grip dynamometer, muscle mass by a BIA device, and physical performance by the 4-m walking test. Data were collected about demographic characteristics, medical history, medication use, and lifestyle factors. Barthel index (BI) was used to evaluate functional status. Self-reported fatigue was assessed using the Fatigue Severity Scale (FSS) and the Visual Analogue Scale (VAS). Sleep difficulties were retrieved by the Athens Insomnia Scale (AIS) and the sleep duration was self-reported. Results: SARC-F was translated and cross-cultural adapted in Greek. In the pre-test 10 persons were recruited aged ≥ 65 years, 5 men and 5 women. The second population consisted of 22 persons aged ≥ 65 years, median age 71, range 65-97, 11 men, 11 women. Inter-rater and test-retest reliability determined by kappa index, both showed a total kappa index of k = 1; p < 0.001 (perfect agreement). Internal consistency by Cronbach’s alpha was 0.657 which indicates an acceptable level of consistency. For the clinical validation of SARC-F and the investigation of possible relationships between sarcopenia and factors in daily life, 100 community-dwelling older adults (median age 72.50 ± 9 years old, 59% women) were recruited. Based on the updated European Working Group on Sarcopenia in Older People definition (EWGSOP2), the prevalence of sarcopenia was 10% in the whole study population, 7% men and 3% women. The Greek version of SARC-F was assessed against four operational definitions of sarcopenia and probable sarcopenia. Based on the definition used for sarcopenia, its sensitivity ranged from 27 to 50%, specificity from 82.2 to 85.7%, negative predictive values (NPVs) between 66.7 and 93.8%, and positive predictive values (PPVs) were always below 60%. The SARC-Calf demonstrated improved specificity (95.6 to 98.4%) but lower sensitivity (10 to 20%) than SARC-F. NPV was similar to that of SARC-F, but PPV was much higher in all cases except for the definition by the Foundation of the National Institutes of Health (FNIH/3 criteria). SARC-F, against probable sarcopenia, demonstrated 42.1% sensitivity, 86.4% specificity, 42.1% PPV, and 86.4% NPV. SARC-Calf, against probable sarcopenia, indicated in contrast to SARC-F, lower sensitivity (10.5%), improved specificity (96.3%), similar NPV (82.1%), and PPV (40%). After the multivariate logistic regression, BI (OR 0.725; 95% CI 0.595 – 0.884, p = 0.001), VAS fatigue (OR 1.435; 95% CI 1.064 – 1.936, p = 0.018), and AIS (OR 1.306; 95% CI 1.053 – 1.620, p = 0.015) seem to predict SARC-F score. A positive association was found between age and probable sarcopenia (OR 1.205; 95% 1.090 – 1.333, p < 0.001) and confirmed sarcopenia (OR 1.192; 95% CI 1.078 – 1.317, p < 0.001). Walking frequency was found to be associated with probable sarcopenia (OR 0.231; 95% CI 0.057 – 0.943, p = 0.041). After multiple linear regression, muscle strength, the key characteristic of sarcopenia, was associated with age (coefficient b -0.356, 95% CI -0.523 – -0.190, p < 0.001), gender (coefficient b -11.107, 95% CI -13.738 – -8.475, p < 0.001), muscle mass (coefficient b 1.200, 95% CI 0.051 – 2.349, p = 0.041), physical performance (coefficient b 6.969, 95% CI 3.357 – 10.581, p < 0.001), number of medications (coefficient b -0.560, 95% CI -0.990 – -0.130, p = 0.011), and alcohol consumption (coefficient b -3.633, 95% CI -6.467 – -0.798, p = 0.013). Conclusions: The Greek version of SARC-F demonstrated perfect inter-rater and test-retest reliability and an acceptable level of consistency. SARC-F appears to be a useful screening tool for nurses, precisely to rule out community-dwelling older adults without sarcopenia. Factors in daily life such as functional status, self-reported fatigue, and sleep difficulties were associated with risk for sarcopenia, based on SARC-F questionnaire. Age was a risk factor for lower muscle strength, probable and confirmed sarcopenia. Walking frequency demonstrated a negative association with probable sarcopenia. Gender, muscle mass, physical performance, number of medications, and alcohol consumption could be used as a predictive indicators of muscle strength. Future research is required to focus on more vulnerable populations for the assessment of SARC-Calf and to include larger samples of older populations to determine significant relationships between sarcopenia and factors in daily life. Moreover, it is important for the future research to focus on the consensus regarding the definition and the diagnostic criteria for sarcopenia.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Pana, Anastasia
  • Πανά, Αναστασία

Subjects

dc:subject × 15

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/54205

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Pana, Anastasia; Πανά, Αναστασία. Investigation of daily life among older adults with sarcopenia. National and Kapodistrian University of Athens, 2023. http://hdl.handle.net/10442/hedi/54205